Skip to main content
Press Enter
BASF offers the world's largest portfolio of chemical raw materials for the pharmaceutical industry, ensuring the needs of our partners are always met. Every step of biopharmaceutical manufacturing requires high-quality raw materials delivered through a transparent, sustainable supply chain. BASF Biopharma Ingredients is committed to meeting your requirements for every ingredient we supply to the biologics industry. At BASF, we create excipients that are safe, effective, and convenient for your customers. Whether you’re developing orally disintegrating formulations that require taste-masking or modified release tablets, BASF has ingredients to deliver the precision you need, every time. At BASF, we offer a comprehensive range of cutting-edge solubilization polymers, and have an unparalleled understanding of the corresponding process technologies. BASF offers an unparalleled portfolio of excipients for topical formulations, enabling you with the tools to overcome formulation challenges. With products based on over 150 years of industry experience, BASF is committed to maintaining the highest level of quality across the product spectrum. BASF offers a broad portfolio of chemistries designed to simplify the product development process. Coating polymers are suitable for a variety of oral formulation challenges. As multifunctional excipients, ethoxylated solubilizers are known for their utility across a large range of dosage form classes. BASF's pharma grade lipid-based excipients are manufactured in GMP-compliant facilities with high quality and reliability in mind. BASF's portfolio of poloxamers are renown for their best-in-class quality. Consisting of a broad portfolio of polyethylene glycols (PEGs), BASF's portfolio of ethoxylated polymer-solubilizers is known for its versatility across a myriad of dosage forms. BASF offers a broad portfolio of functional excipients including our pharmaceutical grade polysorbate and sorbitan esters. Povidones, copovidones, and crospovidones are versatile materials that serve as the foundation of oral solid dosage forms. BASF's portfolio of solvents and co-solvents are suitable for a wide range of applications and processing methodologies. BASF offers a broad portfolio of brand families that are suitable for oral, topical, parenteral, and biologic applications. Coprocessed excipients are combination, all-in-one solutions. Kollicoat® coating polymers are suitable for a variety of oral formulation challenges. Kollicream® pharma grade solvents and emollients are manufactured in GMP-compliant facilities with high quality and reliability in mind. Kollidon® povidones, copovidones, and crospovidones are versatile materials that are most commonly used for solid oral dosage forms. Kolliphor® solubilizers, emulsifiers, co-emulsifiers, and surfactants enable the development of safe and effective formulations. Kollisolv® solubilizers and solvents are suitable for a wide range of applications and processing methodologies. Kolliwax® structuring agents, moisture barriers, and lubricants enable the formulation of various dosage forms. Novata® hard fats are structuring agents and matrix builders. Soluplus® is a novel solubilizer, crystallization inhibitor, and a matrix forming polymer. Explore this collection of resources to learn more about our innovative research and pharma solutions.
  • The collaboration focuses on the development and sharing of Standard Quality and Regulatory Documentation (StaQRD), a standard guide for the electronic transfer of information
  • StaQRD supports the streamlining of data transfers between suppliers and pharmaceutical manufacturers

Florham Park, New Jersey, June, 6, 2023 – BASF Pharma Solutions and the Life Science business of Merck KGaA, Darmstadt, Germany announce the launch of a new standard for the electronic transfer of quality and regulatory documentation from suppliers to users in the pharma/biopharmaceutical industry. The Standard Quality and Regulatory Documentation (StaQRD) electronic data standard includes quality and regulatory compliance data.

A previous eData standard, ASTM-E3077, published by the American Society for Testing and Materials (ASTM), was primarily designed for transferring CoA content and did not include the exchange of additional information. Building on this CoA standard, StaQRD includes nine additional types of compliance documentation in the initial launch, such as nitrosamine risk assessment, allergen statements and GMP compliance documents. StaQRD is available to all suppliers and manufacturers with the goal of facilitating a streamlined electronic documentation exchange while ensuring data integrity, speed and efficiency, and flexible data management.

“Currently, the exchange of quality and regulatory information requires a manual process of transferring text and PDF files and copying and pasting information. The process is not only time-consuming but also prone to errors,” states Dr. Dominik Odenbach, Director Global Quality & Regulatory Compliance & External Affairs, BASF Pharma Solutions. “We developed StaQRD in partnership with the Life Science business of Merck KGaA, Darmstadt, Germany, and with input from leading pharmaceutical companies, to streamline the transfer of quality and regulatory information from suppliers to users using widely adopted Extensible Markup Language (XML) to define the required and optional information, propose exact names for the attributes to ensure consistency, harmonize descriptions and reduce the risk for error,” Dr. Odenbach explains.

“Our customers expect 24/7 access to accurate real-time data and vital information to minimize supplier risk and accelerate the time-to-market for new drug therapies. We are meeting these demands through a growing number of digitalization investments and initiatives, including our collaboration with the Life Science business of Merck KGaA, Darmstadt, Germany to develop StaQRD,” states Marion Kuhn, Vice President Business Management, Pharma Solutions.

The StaQRD document is available to download free of charge. To learn more, visit our new webpage.

About BASF

At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. More than 111,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €87.3 billion in 2022. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Further information at

About BASF’s Nutrition & Health division

BASF Nutrition & Health provides a comprehensive product and service range for human and animal nutrition, pharmaceutical, and flavor & fragrance industries. With our science-driven portfolio, we address customers in globally growing markets to meet the demands of an expanding world population. Together with our customers, we play an active role in enhancing the nutrition, health and wellbeing of consumers all over the world. Our products fulfill the highest safety, regulatory and sustainability standards. BASF Nutrition & Health operates sites in Europe, North America and in Asia-Pacific. For more information, go to

Deb Oliveri 

Pharma Solutions

  • +1 551-252-3567

Rebekka-Martina Müller

Media Relations Nutrition & Health

  • +49 151 65570069
News Release
Thumbnail of document